{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:36:57Z","timestamp":1781199417222,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["2524"],"award-info":[{"award-number":["2524"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The association between oral contraceptives (OCP) and hypertension has been reported in the literature with controversial results. According to the growing use of OCPs among women in Iran, this study aims to investigate the association between the duration of the OCP consumption and risk of hypertension among Iranian women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the current study, the data collected during the enrolment phase of the Tabari cohort were analyzed. Of 6106 women recruited in the cohort, 133 pregnant women were excluded. Epidemiological variables were collected using pre-designed questionnaires as well as the health insurance evidences. In addition, blood pressure and anthropometric factors were measured based on the standard guidelines. Chi square and partial correlation tests as well as logistic regression models were applied for data analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Frequency of oral contraceptive use among 35\u201370 year-old women in Tabari cohort study (TCS) was 42.2% (2520\/5973). Hypertension was observed among 25% (1793\/5973) of them. The adjusted odds ratio for OCP use was 1.23 (95% confidence interval: 1.08, 1.40, <jats:italic>p<\/jats:italic>\u2009=\u20090.002). The corresponding odds ratios for 61\u2013120 months and more than 120 months OCP use were 1.39 (1.12,1.73) and 1.47 (1.16,1.87) respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Oral contraceptives especially in long term use can be associated with hypertension.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-021-01376-4","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T09:34:59Z","timestamp":1622194499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study"],"prefix":"10.1186","volume":"21","author":[{"given":"Mahdi","family":"Afshari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Alizadeh-Navaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Moosazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"issue":"9603","key":"1376_CR1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(07)61696-1","volume":"370","author":"DO Abegunde","year":"2007","unstructured":"Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K: The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007, 370(9603):1929\u20131938.","journal-title":"Lancet"},{"key":"1376_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1471-2458-9-167","volume":"9","author":"A Esteghamati","year":"2009","unstructured":"Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167.","journal-title":"BMC Public Health"},{"key":"1376_CR3","doi-asserted-by":"publisher","first-page":"e040981","DOI":"10.1136\/bmjopen-2020-040981","volume":"10","author":"LP Simo","year":"2020","unstructured":"Simo LP, Agbor VN, Noubiap JJN, et al. Hypertension prevalence, associated factors, treatment and control in rural Cameroon: a cross-sectional study. BMJ Open 2020;10:e040981.","journal-title":"BMJ Open"},{"issue":"1","key":"1376_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12889-017-4536-9","volume":"18","author":"MR Nahimana","year":"2017","unstructured":"Nahimana MR, Nyandwi A, Muhimpundu MA, Olu O, Condo JU, Rusanganwa A, et al. A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: implications for prevention and control. BMC Public Health. 2017;18(1):2.","journal-title":"BMC Public Health"},{"issue":"Suppl 1","key":"1376_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12963-020-00218-z","volume":"18","author":"BR Nascimento","year":"2020","unstructured":"Nascimento BR, Brant LCC, Yadgir S, Oliveira GMM, Roth G, Glenn SD,et al. Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the \u201cGlobal Burden of Disease 2017\u201d (GBD 2017) study. Popul Health Metr. 2020;18(Suppl 1):17.","journal-title":"Popul Health Metr"},{"key":"1376_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1472-6874-13-39","volume":"13","author":"H Park","year":"2013","unstructured":"Park H, Kim K. Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women. BMC Womens Health. 2013;13:39.","journal-title":"BMC Womens Health"},{"issue":"4","key":"1376_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11906-019-0933-z","volume":"21","author":"R Afsargharehbagh","year":"2019","unstructured":"Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: a meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019;21(4):27.","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"1376_CR8","first-page":"279","volume":"22","author":"M Kheradmand","year":"2019","unstructured":"Kheradmand M, Moosazadeh M, Saeedi M, Poustchi H, Eghtesad S, Esmaeili R, et al. Tabari Cohort profile and preliminary results in urban areas and mountainous regions of Mazandaran, Iran. Arch Iran Med. 2019;22(6):279\u201385.","journal-title":"Arch Iran Med"},{"issue":"4","key":"1376_CR9","first-page":"444","volume":"11","author":"AA Haghdoost","year":"2008","unstructured":"Haghdoost AA, Sadeghirad B, Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med. 2008;11(4):444\u201352.","journal-title":"Arch Iran Med"},{"issue":"6","key":"1376_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/jhh.2010.67","volume":"25","author":"W Wei","year":"2011","unstructured":"Wei W, Li Y, Chen F, Chen C, Sun T, Sun Z, et al. Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women. J Hum Hypertens. 2011;25(6):364\u201371.","journal-title":"J Hum Hypertens"},{"key":"1376_CR11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/jch.13042","volume":"19","author":"H Liu","year":"2017","unstructured":"Liu H, Yao J, Wang W, Zhang D. Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens. 2017;19:1032\u201341.","journal-title":"J Clin Hypertens"},{"issue":"3 Pt 2","key":"1376_CR12","first-page":"II11-5","volume":"11","author":"JW Woods","year":"1988","unstructured":"Woods JW. Oral contraceptives and hypertension. Hypertension. 1988;11(3 Pt 2):II11-5.","journal-title":"Hypertension"},{"issue":"2","key":"1376_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2307\/2133437","volume":"20","author":"A Aghajanian","year":"1994","unstructured":"Aghajanian A. Family planning and contraceptive use in Iran, 1967\u20131992. Int Family Plan Perspect. 1994;20(2):66\u20139.","journal-title":"Int Family Plan Perspect"},{"issue":"4","key":"1376_CR14","first-page":"1041","volume":"5","author":"LengKhoo S AsadiSarvestaniKh","year":"2017","unstructured":"AsadiSarvestaniKh, LengKhoo S, MalinaMalek N, Mat Yasin S, Ahmadi A. Comparison of the Determinant Factors of Using the Contraceptive Methods between Rural and Urban Women in Shiraz County, Iran. Journal of Midwifery and Reproductive Health. 2017; 5(4): 1041\u20131052.","journal-title":"Journal of Midwifery and Reproductive Health"},{"issue":"1","key":"1376_CR15","first-page":"47","volume":"6","author":"S Azima","year":"2017","unstructured":"Azima S, Mousavi S. Oral contraceptive pills use and hypertension. Int J Pharm Sci Invent. 2017;6(1):47\u20139.","journal-title":"Int J Pharm Sci Invent"},{"issue":"4","key":"1376_CR16","doi-asserted-by":"publisher","first-page":"S9-S13","DOI":"10.1016\/j.ajog.2011.06.057","volume":"205","author":"LP Shulman","year":"2011","unstructured":"Shulman LP. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Am J Obstet Gynecol. 2011;205(4):S9-S13.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1376_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.contraception.2009.09.009","volume":"81","author":"D Grossman","year":"2010","unstructured":"Grossman D, Fern\u00e1ndez L, Hopkins K, Amastae J, Potter JE. Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas. Contraception. 2010;81(3):254\u201360.","journal-title":"Contraception"},{"key":"1376_CR18","unstructured":"Barikani A, Saeedi F. Prevalence of hypertension in women above 30 years of age in Minoudar, Qazvin, Iran. ARYA Atheroscler J. 2012; 8(special issue in national hypertension treatment): S158\u201362."},{"issue":"2","key":"1376_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/13625180601143462","volume":"12","author":"SM Sadat-Hashemi","year":"2007","unstructured":"Sadat-Hashemi SM, Ghorbani R, Majdabadi HA, Farahani FK. Factors associated with contraceptive use in Tehran, Iran. Eur J Contracept Reprod Health Care. 2007;12(2):148\u201353.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"1376_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647\u201355.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"1376_CR21","first-page":"691","volume":"20","author":"S Eghtesad","year":"2017","unstructured":"Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, et al. The PERSIAN cohort: providing the evidence needed for healthcare reform. Arch Iran Med. 2017;20(11):691\u20135.","journal-title":"Arch Iran Med"},{"issue":"12","key":"1376_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajh.2011.157","volume":"24","author":"C Wang","year":"2011","unstructured":"Wang C, Li Y, Bai J, Qian W, Zhou J, Sun Z, Ba L, Wei W, Li H, Sun T. General and central obesity, combined oral contraceptive use and hypertension in Chinese women. Am J Hypertens. 2011;24(12):1324\u201330.","journal-title":"Am J Hypertens"},{"issue":"3","key":"1376_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40618-015-0346-z","volume":"39","author":"M Farahmand","year":"2016","unstructured":"Farahmand M, Ramezani Tehrani F, Rostami Dovom M, Hashemi S, Azizi F. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest. 2016;39(3):277\u201383.","journal-title":"J Endocrinol Invest"},{"key":"1376_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12889-015-1392-3","volume":"15","author":"CL Chiu","year":"2015","unstructured":"Chiu CL, Lind JM. Past oral contraceptive use and self-reported high blood pressure in postmenopausal women. BMC Public Health. 2015;15:54.","journal-title":"BMC Public Health"},{"issue":"suppl 3","key":"1376_CR25","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1590\/0034-7167-2017-0317","volume":"71","author":"CCM Ribeiro","year":"2018","unstructured":"Ribeiro CCM, Shimo AKK, Lopes MHBM, Lamas JLT. Effects of different hormonal contraceptives in women\u2019s blood pressure values. Rev Bras Enferm. 2018;71(suppl 3):1453\u20131459.","journal-title":"Rev Bras Enferm"},{"issue":"4","key":"1376_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/archinte.1970.00310100067006","volume":"126","author":"T Saruta","year":"1970","unstructured":"Saruta T, Saade GA, Kaplan NM. A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release. Arch Intern Med. 1970;126(4):621\u20136.","journal-title":"Arch Intern Med"},{"key":"1376_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","volume":"12","author":"KM Fedak","year":"2015","unstructured":"Fedak KM, Bernal A, Capshaw ZA, Gross S. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 2015;12:14.","journal-title":"Emerg Themes Epidemiol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-021-01376-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-021-01376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T09:36:49Z","timestamp":1622194609000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-021-01376-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1186\/s12905-021-01376-4","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"25 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TCS was confirmed by Mazandaran University of Medical science ethical committee (IR.MAZUMS.  REC.1395.2524).All ethical principles of the Helsinki ethical declaration have been met and written informed consent were obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no Competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"224"}}